Abstract
Dolichol phosphate mannose synthase (DPMS) is an inverting GT-A-folded enzyme and classified as GT2 by CAZy. DPMS sequence carries a metal-binding DXD motif, a PKA motif, and a variable number of hydrophobic domains. Human and bovine DPMS possess a single transmembrane domain, whereas that from S. cerevisiae and A. thaliana carry multiple transmembrane domains and are superimposable. The catalytic activity of DPMS is documented in all spheres of life, and the 32kDa protein is uniquely regulated by protein phosphorylation. Intracellular activation of DPMS by cAMP signaling is truly due to the activation of the enzyme and not due to increased Dol-P level. The sequence of DPMS in some species also carries a protein N-glycosylation motif (Asn-X-Ser/Thr). Apart from participating in N-glycan biosynthesis, DPMS is essential for the synthesis of GPI anchor as well as for O- and C-mannosylation of proteins. Because of the dynamic nature, DPMS actively participates in cellular proliferation enhancing angiogenesis and breast tumor progression. In fact, overexpression of DPMS in capillary endothelial cells supports increased N-glycosylation, cellular proliferation, and enhanced chemotactic activity. These are expected to be completely absent in congenital disorders of glycosylation (CDGs) due to the silence of DPMS catalytic activity. DPMS has also been found to be involved in the cross talk with N-acetylglucosaminyl 1-phosphate transferase (GPT). Inhibition of GPT with tunicamycin downregulates the DPMS catalytic activity quantitatively. The result is impairment of surface N-glycan expression, inhibition of angiogenesis, proliferation of human breast cancer cells, and induction of apoptosis. Interestingly, nano-formulated tunicamycin is three times more potent in inhibiting the cell cycle progression than the native tunicamycin and is supported by downregulation of the ratio of phospho-p53 to total-p53 as well as phospho-Rb to total Rb. DPMS expression is also reduced significantly. However, nano-formulated tunicamycin does not induce apoptosis. We, therefore, conclude that DPMS could become a novel target for developing glycotherapy treating breast tumor in the clinic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baksi K, Tavárez-Pagán JJ, Martínez JA, Banerjee DK (2008) Unique structural motif supports mannosylphospho dolichol synthase: an important angiogenesis regulator. Curr Drug Targets 9:262–271
Banerjee DK (1988) Microenvironment of endothelial cell growth and regulation of protein N-glycosylation. Indian J Biochem Biophys 25:8–13
Banerjee DK (1989) Amphomycin inhibits mannosylphosphoryldolichol synthesis by forming a complex with dolichylmonophosphate. J Biol Chem 264:2024–2028
Banerjee DK (1994) A recent approach to the study of dolichyl monophosphate topology in the rough endoplasmic reticulum. Acta Biochim Pol 41:275–280
Banerjee DK (2012) N-glycans in cell survival and death: cross-talk between glycosyltransferases. Biochim Biophys Acta 1820:1338–1346
Banerjee DK, Scher MG, Waechter CJ (1981) Amphomycin: effect of the lipopeptide antibiotic on the glycosylation and extraction of dolichyl monophosphate in calf brain membranes. Biochemistry 20:1561–1568
Banerjee DK, Kousvelari EE, Baum BJ (1985) beta-Adrenergic activation of glycosyltransferases in the dolichylmonophosphate-linked pathway of protein N-glycosylation. Biochem Biophys Res Commun 126:123–129
Banerjee DK, Kousvelari EE, Baum BJ (1987) cAMP-mediated protein phosphorylation of microsomal membranes increases mannosylphospho dolichol synthase activity. Proc Natl Acad Sci (USA) 84:6389–6393
Banerjee DK, Tavárez JJ, Oliveira CM (1992) Expression of blood clotting factor VIII:C gene in capillary endothelial cells. FEBS Lett 306:33–37
Banerjee DK, DaSilva JJ, Bigio B (1999) Mannosylphosphodolichol synthase activity is associated with a 32 kDa phosphoprotein. Biosci Rep 19:169–177
Banerjee A, Lang JY, Hung MC, Sengupta K, Banerjee SK, Baksi K, Banerjee DK (2011a) Unfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin. J Biol Chem 286:29127–29138
Banerjee DK, Oliveira CM, Tavárez JJ, Katiyar VN, Saha S, Martínez JA, Banerjee A, Sánchez A, Baksi K (2011b) Importance of a factor VIIIc-like glycoprotein expressed in capillary endothelial cells (eFactor VIIIc) in angiogenesis. Adv Exp Med Biol 705:453–464
Banerjee A, Johnson KT, Banerjee IA, Banerjee DK (2013) Nanoformulation enhances anti-angiogenic efficacy of tunicamycin. Transl Cancer Res 2:240–255
Banerjee A, Martinez JA, Longas MO, Zhang Z, Santiago J, Baksi K, Banerjee DK (2015) N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic. Adv Exp Med Biol 842:355–374
Banerjee DK, Zhang Z, Baksi K, Serrano-Negrón JE (2017) Dolichol phosphate mannose synthase: A Glycosyltransferase with Unity and molecular diversities. Glycoconj J 34:467–479
Bujnicki JM, Elofsson A, Fischer D, Rychlewski L (2001) Structure prediction meta server. Bioinformatics 17:750–751
Calo D, Kaminski L, Eichler J (2010) Protein glycosylation in Archaea: sweet and extreme. Glycobiology 20:1065–1076
Fay PJ (1999) Regulation of factor VIIIa in the intrinsic factor Xase. Thromb Haemost 82:193–200
Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6:273–286
Gandini R, Reichenbach T, Tan T, Divne C (2017) Structural basis for dolichylphosphate mannose biosynthesis. Nat Commun 8:1–12
Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. In: Walker JM (ed) The proteomics protocols handbook. Humana Press, Totowa, pp 571–607
Gastl G, Hermann T, Steurer M, Zmija J, Gunsilius E, Unger C, Kraft A (1997) Angiogenesis as a target for tumor treatment. Oncology 54:177–178
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Helenius A, Aebi M (2004) Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem 73:1019–1049
Kane WH, Davie EW (1988) Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71:539–555
Kean EL (1982) Activation by dolichol phosphate-mannose of the biosynthesis of N-acetyl- glucosaminylpyrophosphoryl polyprenols by the retina. J Biol Chem 257:7952–7954
Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:6631–6636
Kyte J. Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105–132
Lamani E, Mewbourne RB, Fletcher DS, Maltsev SD, Danilov LL, Veselovsky VV, Lozanova AV, Grigorieva NY, Pinsker OA, Xing J, Forsee WT, Cheung HC, Schutzbach JS, Shibaev VN, Jedrzejas MJ (2006) Structural studies and mechanism of Saccharomyces cerevisiae dolichyl-phosphatemannose synthase: insights into the initial step of synthesis of dolichyl-phosphate-linked oligosaccharide chains in membranes of endoplasmic reticulum. Glycobiology 16:666–678
Lenting PJ, van Mourik JA, Mertens K (1998) The life cycle of coagulation factor VIII in view of its structure and function. Blood 92:3983–3996
Martinez JA (2002) Angiogenesis and Glycosylation: interplay between dolichol cycle and cell cycle. In: Ph.D. thesis, University of Puerto Rico School of Medicine, San Juan, PR, pp 1–233
Nguyen M, Folkman J, Bischoff J (1992) 1-Deoxymannojirimycin inhibits capillary tube formation in vitro. Analysis of N-linked oligosaccharides in bovine capillary endothelial cells. J Biol Chem 267:26157–26165
Nguyen M, Strubel NA, Bischoff J (1993) A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365:267–269
Pili R, Chang J, Partis RA, Mueller RA, Chrest FJ, Passaniti A (1995) The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res 55:2920–2926
Schneider BP, Miller KD (2005) Angiogenesis of breast cancer. J Clin Oncol 23:1782–1790
Sinhoara H, Maruyama T (1973) Evolution of glycoproteins as judged by the frequency of occurrence of the tripeptides Asn-X-Ser and Asn-X-Thr in proteins. J Mol Evol 2:117–122
Szymanski CM, Wren BW (2005) Protein glycosylation in bacterial mucosal pathogens. Nat Rev Microbiol 3:225–237
Tarbouriech N, Charnock SJ, Davies GJ (2001) Three-dimensional structures of the Mn and Mg dTDP complexes of the family GT-2 glycosyltransferase SpsA: a comparison with related NDP-sugar glycosyltransferases. J Mol Biol 314:655–661
Uhr JW, Scheuermann RH, Street NE, Vitetta ES (1997) Cancer dormancy: opportunities for new therapeutic approaches. Nat Med 3:505–509
Zhang Z, Banerjee A, Baksi K, Banerjee DK (2010) Mannosylphosphodolichol synthase overexpression supports angiogenesis. Biocatal Biotransformation 28:90–98
Acknowledgment
This work is partly supported by funds from the Office of the Dean, School of Medicine, University of Puerto Rico, and grants from the Department of Defense DAMD17-03-1-0754, the National Institutes of Health NIH U54-CA096297, Susan G. Komen for the Cure BCTR0600582, the National Science Foundation NSF EPS-1002410 (DKB), and the National Institutes of Health NIH/NIMHD 2G12MD007583 (KB).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Zhang, Z., Serrano-Negrón, J.E., Martínez, J.A., Baksi, K., Banerjee, D.K. (2018). Dynamic Function of DPMS Is Essential for Angiogenesis and Cancer Progression. In: Chattopadhyay, K., Basu, S. (eds) Biochemical and Biophysical Roles of Cell Surface Molecules. Advances in Experimental Medicine and Biology, vol 1112. Springer, Singapore. https://doi.org/10.1007/978-981-13-3065-0_16
Download citation
DOI: https://doi.org/10.1007/978-981-13-3065-0_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3064-3
Online ISBN: 978-981-13-3065-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)